<p>Needham 分析师 Gerald Pascarelli 重申了对 VITL 股票的看涨态度，今天给予了买入评级。</p>
<h3>享受 TipRanks Premium 50% 折扣，自信投资</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，帮助您做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，使您的投资组合始终处于最大潜力的状态</li>
</ul>
<p>Gerald Pascarelli 给予买入评级的原因是多种因素的结合，这些因素突显了 Vital Farms 令人鼓舞的长期增长潜力，尽管短期收入略有调整。该公司将 2025 年的收入预测略微下调了不到 2%，虽然这一调整出乎意料，但并不反映当前的需求问题。这一调整可能会暂时掩盖其强劲的财务前景，包括维持 2025 年 EBITDA 目标和减少资本支出。</p>
<p>Vital Farms 将其增长前景延伸至 2030 年，目标是实现显著的收入和利润率改善。该公司预计到 2030 年的收入目标为 20 亿美元，毛利率超过 35%，EBITDA 利润率在 15% 到 17% 之间。这一雄心勃勃的计划表明，从 2025 年的基数来看，复合年增长率超过 21%，显示出强劲的未来表现。尽管短期市场可能出现过度反应，Pascarelli 对公司的战略方向和长期前景依然充满信心。</p>

VITL

<p>Needham 分析师 Gerald Pascarelli 对 Vital Farms (VITL) 股票维持买入评级，指出尽管短期收入有所小幅调整，但其长期增长潜力依然强劲。该公司略微下调了 2025 年的收入预测，但维持其 EBITDA 目标，并计划到 2030 年实现显著增长，目标收入为 20 亿美元。Pascarelli 对公司的战略方向和长期前景充满信心</p>

<p>Needham analyst Gerald Pascarelli has reiterated their bullish stance on VITL stock, giving a Buy rating today.</p>
<div class="lb-trans"><p>Needham 分析师 Gerald Pascarelli 重申了对 VITL 股票的看涨态度，今天给予了买入评级。</p>
</div><h3>Claim 50% Off TipRanks Premium and Invest with Confidence</h3>
<div class="lb-trans"><h3>享受 TipRanks Premium 50% 折扣，自信投资</h3>
</div><ul>
<li>Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，帮助您做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，使您的投资组合始终处于最大潜力的状态</li>
</ul>
</div><p>Gerald Pascarelli has given his Buy rating due to a combination of factors that highlight Vital Farms’ promising long-term growth potential despite a minor short-term revenue adjustment. The company has slightly reduced its 2025 revenue forecast by less than 2%, which, although unexpected, does not reflect current demand issues. This adjustment may temporarily overshadow the otherwise strong financial outlook, which includes maintaining its 2025 EBITDA target and reducing capital expenditures.</p>
<div class="lb-trans"><p>Gerald Pascarelli 给予买入评级的原因是多种因素的结合，这些因素突显了 Vital Farms 令人鼓舞的长期增长潜力，尽管短期收入略有调整。该公司将 2025 年的收入预测略微下调了不到 2%，虽然这一调整出乎意料，但并不反映当前的需求问题。这一调整可能会暂时掩盖其强劲的财务前景，包括维持 2025 年 EBITDA 目标和减少资本支出。</p>
</div><p>Vital Farms has extended its growth outlook to 2030, aiming for significant revenue and margin improvements. The company projects a revenue target of $2 billion by 2030, with a gross margin exceeding 35% and an EBITDA margin between 15-17%. This ambitious plan suggests a compound annual growth rate of over 21% from the 2025 base, indicating robust future performance. Despite the potential for short-term market overreactions, Pascarelli remains confident in the company’s strategic direction and long-term prospects.</p>
<div class="lb-trans"><p>Vital Farms 将其增长前景延伸至 2030 年，目标是实现显著的收入和利润率改善。该公司预计到 2030 年的收入目标为 20 亿美元，毛利率超过 35%，EBITDA 利润率在 15% 到 17% 之间。这一雄心勃勃的计划表明，从 2025 年的基数来看，复合年增长率超过 21%，显示出强劲的未来表现。尽管短期市场可能出现过度反应，Pascarelli 对公司的战略方向和长期前景依然充满信心。</p>
</div>

Vital Farms：长期增长潜力胜过短期收入的小幅调整